Disparities in tyrosine kinase inhibitor use in older patients with gastrointestinal stromal tumors

J Geriatr Oncol. 2023 May;14(4):101441. doi: 10.1016/j.jgo.2023.101441. Epub 2023 Jan 28.

¹ Division of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN, USA. Electronic address: [email protected].
² Health Services Advisory Group, 3133 E Camelback Rd STE 100, Phoenix, AZ, USA.
³ Kern Center for Science of Health Care Delivery, Mayo Clinic, 200 First St SW, Rochester, MN, USA.
⁴ Division of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN, USA.
⁵ Division of General Surgery, Mayo Clinic, 200 First St SW, Rochester, MN, USA.

No abstract available

Keywords: Gastrointestinal stromal tumor (GIST); Older patients; Population study; Sarcoma; Tyrosine kinase inhibitor (TKI).

Publication types